Phase I open study of the effects of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer

AM Gillespie, T Broadhead, Stephen Chan, John R. Owen, APH Farnsworth, Mark Sopwith, Robert E. Coleman

Annals of Oncology · 2000 · 41 citations · 17 references

Concepts

References

17